Open AccessCannabis: Joints of Mental Illness
Author(s) -
Nandini. H. B,
C Yashaswini.,
Harsha. A. M
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v71i02.010
Subject(s) - cannabis , cannabidiol , psychiatry , mental illness , effects of cannabis , medicine , population , schizophrenia (object oriented programming) , anxiety , tetrahydrocannabinol , mental health , cannabinoid , environmental health , receptor
With the increasing push to legalise cannabis in western nations there is an estimation that the potential impact of this policy changeon vulnerable population such as those with mental illness, including schizophrenia, mood and anxiety disorders. Cannabis is the mostlikely used illicit drug worldwide. Cannabis sativa is an important herbaceous species originating from central Asia which has beenused in folk medicine. Despite the widespread use of cannabis among young people little research attention has been given to thedevelopment of pscyhometrically sound measures specific to cannabis related problems. The laws governing cannabis are evolvingworldwide are associated with changing pattern of use. Patients with a serious mental illness often use cannabis at higher rates thanthe general population. Cannabis may induce or exaberate a number of mental health problems. The main psychoactive drug incannabis is ?9 tetrahydrocannabinol (THC). Cannabidiol, a non-toxicating cannabinoid found in some forms of cannabis, may offsetsome of these acute effects. Chronic use of cannabis is associated with psychiatric, respiratory, cardiovascular and bone effects. Italso has oncogenic, teratogenic and mutagenic effects, all of which depend upon dose and duration of use. The present article mainlyreviews about the association between cannabis and mental health.